Table 1

Baseline characteristics

RACED follow-up substudy participants (n = 411)The rest of the VADT participants (n = 1,380)
Intensive treatment (%)5149
Age (years)58 ± 861 ± 9*
Non-Hispanic white (%)6462
Female (%)43
Smoking history (pack-years)10 (0–30)15 (0–40)*
History of hypertension (%)6973
Prior CVD (%)3442*
Diabetes duration (years)11 ± 712 ± 7
BMI (kg/m2)31.2 ± 4.331.2 ± 4.5
HbA1c (%)9.4 ± 1.49.4 ± 1.5
Fasting glucose (mg/dL)204 ± 65204 ± 69
Total cholesterol (mg/dL)181 ± 44184 ± 48
LDL cholesterol (mg/dL)115 ± 96110 ± 48
HDL cholesterol (mg/dL)36 ± 1036 ± 10
Triglycerides (mg/dL)158 (112–236)163 (112–238)
GFR-MDRD (mL/min/1.73 m2)81 (69–93)79 (67–95)
  • Data are means ± SD or median (25th to 75th percentiles), unless otherwise indicated. P values were determined by independent-samples t test, Wilcoxon test, or χ2 test, as appropriate.

  • *P < 0.05.